Recent Updates
Recently added Catalysts
LLY Positive Sentiment

GoodRx Expands Access to Eli Lilly and Company’s New Oral GLP-1, Foundayo™, and Zepbound® KwikPen® with Self-Pay Pricing at More Than 70,000 Pharmacies Nationwide

Thursday, April 9, 2026 BiopharmaWatch Research 1 min read
Add on Google
Key Takeaway: GoodRx has partnered with Eli Lilly to enhance access to the newly FDA-approved oral GLP-1 medication, Foundayo. Self-pay patients can obtain Foundayo through GoodRx at a starting price of $149 per month. This initiative aims to provide transparent pricing and improve medication accessibility across more than 70,000 pharmacies nationwide.
Price reaction · baseline $953.3 (2026-04-08 close) · hit after-hours · 4 other LLY headline(s) in the window, move may be shared
day 0 close
+0.2%

Market Sentiment Analysis

POSITIVE FACTORS

  • GoodRx expands access to a new medication.
  • Foundayo offers transparent pricing for patients.
  • Eligible patients can access the medication at a competitive price.

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+45%
120-day peak, hindsight
Typical move
2%
average across 15 past catalysts
Lead asset
Dulaglutide
Phase 3 · Type 2 Diabetes Mellitus

Full Press Release Details

SANTA MONICA, Calif.--(BUSINESS WIRE)--GoodRx (Nasdaq: GDRX), the leading platform for prescription savings in the U.S., today announced that it is working with Eli Lilly and Company to expand access to the newly FDA-approved oral GLP-1 medication, Foundayo™ (orforglipron). Eligible self-pay patients can access Foundayo through GoodRx at a starting price of $149 per month, in line with the lowest available discounted cash price at launch. The offering provides transparent pricing and nationwide

Frequently Asked Questions

What is Foundayo?

Foundayo is a newly FDA-approved oral GLP-1 medication developed by Eli Lilly.

How can patients access Foundayo?

Patients can access Foundayo through GoodRx at a starting price of $149 per month.

Where is Foundayo available?

Foundayo is available at more than 70,000 pharmacies nationwide.

What is the purpose of GoodRx's partnership with Eli Lilly?

The partnership aims to expand access to Foundayo and provide transparent pricing for patients.

ShareAdd on Google
Tags: LLY Viatris Investor Conferences Healthcare GoodRx Eli Lilly Foundayo oral GLP-1 self-pay pricing
Last updated: Apr 9, 2026

Biotech snapshot

Cash runway
$8950M liquidity · $0M/mo burn
Low dilution risk
Lead asset
DulaglutidePhase 3
Type 2 Diabetes Mellitus →

Catalyst track record

+45%
best trade around LLY's most recent catalyst

Peak hindsight return over a 120-day window, across 15 tracked FDA/PDUFA catalysts for LLY.

See every catalyst's timing & PoA →